1.Synergistic regulation of the acute phase protein SIP24/24p3 by glucocorticoid and pro-inflammatory cytokines.
Quan-Sheng LIU ; Marit NILSEN-HAMILTON ; Si-Dong XIONG
Acta Physiologica Sinica 2003;55(5):525-529
SIP24/24p3 is a secreted murine acute phase protein which has been speculated to play an anti-inflammatory role in vivo. Recently SIP24/24p3 has been found to be able to specifically induce apoptosis in leukocytes. By using (35)S metabolic labeling method, we studied the regulation of SIP24/24p3 by glucocorticoid and pro-inflammatory cytokines IL-6 and TNF-alpha in cultured Balb/c 3T3 and BNL cells. The following results were observed: (1) dexamethasone induced the expression of SIP24/24p3 in both Balb/c 3T3 and BNL cells, the induction was more significant in BNL cells; (2) dexamethasone and IL-6 synergistically induced the expression of SIP24/24p3 in both Balb/c 3T3 and BNL cells; (3) in Balb/c 3T3 cells dexamethasone and TNF-alpha acted synergistically to induce the expression of SIP24/24p3, whereas in BNL cells dexamethasone and TNF-alpha induced the expression of SIP24/24p3 in an additive manner; (4) dexamethasone and IL-6/TNF-alpha acted synergistically in Balb/c 3T3 cells and additively in BNL cells to induce the expression of SIP24/24p3. The inducibility of SIP24/24p3 by multiple factors will help to explain its highly specific expression in vivo. The difference in the expression patterns of SIP24/24p3 in different cell types is also suggestive to its expression and regulation in hepatic and extrahepatic tissues. Finally, the fact that SIP24/24p3 protein can be induced by both pro-inflammatory as well as anti-inflammatory factors is indicative of the important role of SIP24/24p3 in the entire acute phase response process.
Acute-Phase Proteins
;
biosynthesis
;
genetics
;
Animals
;
BALB 3T3 Cells
;
Carrier Proteins
;
biosynthesis
;
genetics
;
Cytokines
;
pharmacology
;
Dexamethasone
;
pharmacology
;
Drug Synergism
;
Gene Expression Regulation
;
Interleukin-6
;
pharmacology
;
Lipocalin-2
;
Lipocalins
;
Mice
;
Mice, Inbred BALB C
;
Oncogene Proteins
;
biosynthesis
;
genetics
;
RNA, Messenger
;
biosynthesis
;
genetics
;
Tumor Necrosis Factor-alpha
;
pharmacology
2.Expression of Neutrophil Gelatinase-Associated Lipocalin in Calcium-Induced Keratinocyte Differentiation.
Jeung Hoon LEE ; Kyung Chae KYE ; Eun Young SEO ; Kyungmoon LEE ; Sang Keun LEE ; Jong Soon LIM ; Young Joon SEO ; Chang Deok KIM ; Jang Kyu PARK
Journal of Korean Medical Science 2008;23(2):302-306
In a previous search for the differentially expressed genes in keratinocyte differentiation, we identified neutrophil gelatinase-associated lipocalin (NGAL) as a calcium- induced gene. In this study, we further verified the expression of NGAL in cultured keratinocytes as well as in several skin diseases. Reverse transcription-polymerase chain reaction (RT-PCR), Western blot, and ELISA clearly showed that NGAL expression was markedly increased in calcium-induced keratinocyte differentiation in vitro. However, in our previous report, NGAL expression was not detected in normal skin tissue except for hair follicle by in situ hybridization and immunohistochemistry, indicating the difference of cell status between in vitro and in vitro conditions. Interestingly, NGAL expression was highly increased in psoriasis-like inflammatory disorders (lichen planus and pityriasis rubura pilaris) and skin cancers (keratoacanthoma and squamous cell carcinoma), implying that NGAL may be related with the epidermal hyperplasia. Collectively, these results reveal the potential importance of NGAL in the maintenance of skin homeostasis.
Acute-Phase Proteins/*biosynthesis
;
Calcium/*metabolism
;
Cell Differentiation
;
Culture Media
;
Culture Media, Conditioned
;
Enzyme-Linked Immunosorbent Assay
;
*Gene Expression Regulation
;
Homeostasis
;
Humans
;
Keratinocytes/enzymology
;
Lipocalins/*biosynthesis
;
Models, Biological
;
Proto-Oncogene Proteins/*biosynthesis
;
Psoriasis/enzymology
;
Reverse Transcriptase Polymerase Chain Reaction
;
Skin/*metabolism
;
Skin Neoplasms/enzymology
3.Acute Effects of Intravenous Administration of Pamidronate in Patients with Osteoporosis.
Mie Jin LIM ; Seong Ryul KWON ; Shin Goo PARK ; Won PARK
Journal of Korean Medical Science 2010;25(9):1277-1283
We investigated acute effects of intermittent large dose bisphophonate therapy in osteoporotic patients. Peripheral blood mononuclear cells were incubated with alendronate (100 micrometer) for 18 hr, in vitro and cytokine expressions were measured by real-time RT-PCR. Pamidronate 30 mg was administered on 26 osteoporotic patients; and acute phase reactants, inflammatory cytokines and bone biomarkers were measured. The in vitro study showed significant increase in mRNA expression of IL-6, TNF-alpha and IFN-gamma. A notable rise in serum C-reactive protein (CRP) was observed over 3 days after pamidronate infusion (P=0.026). Serum levels of TNF-alpha, IL-6 and IFN-gamma were also significantly increased (P=0.009, 0.014, 0.035, respectively) and the increase in IL-6 levels were strongly correlated with CRP levels (P=0.04). Serum calcium and c-telopeptide levels rapidly decreased after the treatment (P=0.02, <0.001, respectively). This study showed that mRNA expression of inflammatory cytokines at peripheral blood mononuclear cells (PBMC) level were observed within 18 hr and marked elevation of inflammatory cytokines and acute phase reactants were demonstrated after pamidronate infusion at the dose for osteoporosis. Our studies confirmed that intermittent large dose aminobisphosphonate causes acute inflammation.
Acute-Phase Proteins/biosynthesis/genetics
;
Adult
;
Aged
;
Aged, 80 and over
;
Alendronate/pharmacology
;
Biological Markers/blood
;
Blood Cells/drug effects
;
Bone Density Conservation Agents/*administration & dosage
;
C-Reactive Protein/genetics/metabolism
;
Calcium/blood
;
Collagen Type I/blood
;
Diphosphonates/*administration & dosage
;
Female
;
Humans
;
Injections, Intravenous
;
Interferon-gamma/blood/genetics
;
Interleukin-6/blood/genetics
;
Male
;
Middle Aged
;
Osteoporosis/*drug therapy
;
Peptides/blood
;
RNA, Messenger/metabolism
;
Tumor Necrosis Factor-alpha/genetics/metabolism
4.Rhamnogalacturonan II is a Toll-like receptor 4 agonist that inhibits tumor growth by activating dendritic cell-mediated CD8+ T cells.
Sung Nam PARK ; Kyung Tae NOH ; Young Il JEONG ; In Duk JUNG ; Hyun Kyu KANG ; Gil Sun CHA ; Su Jung LEE ; Jong Keun SEO ; Dae Hwan KANG ; Tae Ho HWANG ; Eun Kyung LEE ; Byungsuk KWON ; Yeong Min PARK
Experimental & Molecular Medicine 2013;45(2):e8-
We evaluated the effectiveness of rhamnogalacturonan II (RG-II)-stimulated bone marrow-derived dendritic cells (BMDCs) vaccination on the induction of antitumor immunity in a mouse lymphoma model using EG7-lymphoma cells expressing ovalbumin (OVA). BMDCs treated with RG-II had an activated phenotype. RG-II induced interleukin (IL)-12, IL-1beta, tumor necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma) production during dendritic cell (DC) maturation. BMDCs stimulated with RG-II facilitate the proliferation of CD8+ T cells. Using BMDCs from the mice deficient in Toll-like receptors (TLRs), we revealed that RG-II activity is dependent on TLR4. RG-II showed a preventive effect of immunization with OVA-pulsed BMDCs against EG7 lymphoma. These results suggested that RG-II expedites the DC-based immune response through the TLR4 signaling pathway.
Acute-Phase Proteins/metabolism
;
Adaptor Proteins, Vesicular Transport/metabolism
;
Animals
;
Antigens, CD14/metabolism
;
Bone Marrow Cells/cytology/drug effects
;
CD8-Positive T-Lymphocytes/*immunology
;
Carrier Proteins/metabolism
;
Cell Differentiation/drug effects
;
Cell Nucleus/drug effects/metabolism
;
Cell Proliferation/drug effects
;
Cytokines/biosynthesis
;
Dendritic Cells/cytology/drug effects/enzymology/*immunology
;
Enzyme Activation/drug effects
;
Lymphocyte Activation/*drug effects
;
Membrane Glycoproteins/metabolism
;
Mice
;
Mice, Inbred C57BL
;
Mice, Knockout
;
Mitogen-Activated Protein Kinases/metabolism
;
Myeloid Differentiation Factor 88/metabolism
;
NF-kappa B/metabolism
;
Neoplasms/immunology/*pathology
;
Pectins/*pharmacology
;
Phenotype
;
Protein Transport/drug effects
;
Receptors, Chemokine/metabolism
;
Signal Transduction/drug effects
;
T-Lymphocytes, Cytotoxic/cytology/drug effects
;
Toll-Like Receptor 4/*agonists/metabolism